Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sohaib Irfan
Institutions:
Aga Khan University,
The University of Texas MD Anderson Cancer Center,
New York Medical College,
Aga Khan University Hospital,
University of Kansas Medical Center
Observed institutions:
Aga Khan University,
The University of Texas MD Anderson Cancer Center,
New York Medical College,
Aga Khan University Hospital,
University of Kansas Medical Center
ORCID:
0009-0008-3133-5993
Observed ORCID:
0009-0008-3133-5993
OpenAlex ID:
A5109769248
Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis
2024
·
Moazzam Shahzad
, Qamar Iqbal
, et al.
·
Leukemia Research
·
10
Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study
2025
·
Sohaib Irfan
, Fathima Shehnaz Ayoobkhan
, et al.
·
Transplantation and Cellular Therapy
·
7
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) for Chimeric Antigen Receptor T-Cell Therapy (CAR-T) and T-Cell Engager Antibody (TCE) in Myeloma and Lymphoma
2024
·
Fathima Shehnaz Ayoobkhan
, Raabia Qureshi
, et al.
·
Blood
·
7
PDF
Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
2025
·
Moazzam Shahzad
, Muhammad Kashif Amin
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
PDF
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis
2025
·
Moazzam Shahzad
, Muhammad Kashif Amin
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
PDF
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines
2025
·
Aqeeb Ur Rehman
, Fathima Shehnaz Ayoobkhan
, et al.
·
Bone Marrow Transplantation
·
2
Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review
2025
·
Moazzam Shahzad
, Hana Qasim
, et al.
·
Transplantation and Cellular Therapy
·
2
Outcomes with Venetoclax and Hypomethylating Agents in Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
2025
·
Moazzam Shahzad
, Aqsa Mumtaz
, et al.
·
Transplantation and Cellular Therapy
·
2
Impact of Donor Age and Gender on Allogeneic Hematopoietic Stem Cell Transplantation
2024
·
Matthew McGuirk
, Moazzam Shahzad
, et al.
·
Blood
·
2
PDF
Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review
2024
·
Moazzam Shahzad
, Hana Qasim
, et al.
·
Blood
·
2
Correlates of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
2024
·
Matthew McGuirk
, Moazzam Shahzad
, et al.
·
Blood
·
2
PDF
Impact of Putative Cell of Origin on CD19+CAR-T Outcomes in Patients with Large B-cell Lymphoma
2026
·
Muhammad Bilal Abid
, Lei Feng
, et al.
·
Transplantation and Cellular Therapy
·
1
Pregnancy-associated atypical hemolytic uremic syndrome: A systematic review and meta-analysis of clinical features, treatment strategies, and Maternal–Fetal outcomes
2025
·
Aminah Tayyab
, Anas Al-sadi
, et al.
·
Blood
·
1
PDF
Neurologic Adverse Events Associated With T-cell Engager Therapy in Multiple Myeloma: A Pharmacovigilance Study
2025
·
Muhammad Atif Khan
, Faiza Humayun Khan
, et al.
·
Cureus
·
1
PDF
Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Moazzam Shahzad
, Sohaib Irfan
, et al.
·
Transplantation and Cellular Therapy
·
1
Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis
2025
·
Moazzam Shahzad
, Abhinav Vyas
, et al.
·
Transplantation and Cellular Therapy
·
1
Clinical outcomes of immunotherapy in metastatic pancreatic carcinoma: A systematic review and meta-analysis.
2025
·
Moazzam Shahzad
, Abhinav Vyas
, et al.
·
Journal of Clinical Oncology
·
1
Outcomes with Venetoclax and Hypomethylating Agents in Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
2024
·
Moazzam Shahzad
, Aqsa Mumtaz
, et al.
·
Blood
·
1
Sociodemographic and Patient-Related Determinants of Outcomes after Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
2024
·
Sibgha Gull Chaudhary
, Moazzam Shahzad
, et al.
·
Blood
·
1
PDF
Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation
2024
·
Sibgha Gull Chaudhary
, Moazzam Shahzad
, et al.
·
Blood
·
1
PDF
Impact of Minimal Residual Disease Status on Multiple Myeloma Outcomes: A Systematic Review
2024
·
Muhammad Kashif Amin
, Sohaib Irfan
, et al.
·
Blood
·
1
Thromboprophylaxis By Direct Oral Anticoagulants Versus Low Molecular Weight Heparin in Patients Undergoing Surgery for Gynecological Cancer: A Systematic Review and Meta-Analysis
2024
·
Prashil Dave
, Anwar Uddin
, et al.
·
Blood
·
1
RNA Interference Therapeutics for Hereditary Transthyretin-Mediated Amyloidosis with Neuropathy: A Systematic Review
2024
·
Prashil Dave
, Yakubu Aliu Opeyemi
, et al.
·
Blood
·
1
Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
2024
·
Moazzam Shahzad
, Sohaib Irfan
, et al.
·
Blood
·
1
Outcomes of Hematopoietic Stem Cell Transplantation in Primary Plasma Cell Leukemia: A Systematic Review and Meta-Analysis
2024
·
Qamar Iqbal
, Sohaib Irfan
, et al.
·
Blood
·
1
PDF
Show more works
View as search
Works count:
57
Citation count:
57
H-index:
4
I10-index:
1
Year
Topic
Type